An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)
Clinical trial NCT03675126 · TERMINATED
Trial details
- NCT number
- NCT03675126
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2021-08-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.